Can TMS Help After Antidepressants Fail?

Written by Neuro Wellness TMS Centers of AmericaMedically reviewed by Daniel Pietras, MDPublished November 3, 2026Last medically reviewed November 3, 2026Last updated November 3, 2026

Yes. TMS (transcranial magnetic stimulation) is FDA-cleared specifically for adults with major depressive disorder who have not improved on antidepressant medication. It uses magnetic pulses to stimulate brain regions involved in mood regulation, working through a different mechanism than medication. In a 301-person randomized trial, active TMS was superior to sham, and a real-world study reported about 58% response and 37% remission. TMS does not work for everyone, and individual results vary. A psychiatric evaluation determines whether TMS is appropriate.

Key takeaways

TMS is FDA-cleared for adults whose depression hasn't improved on antidepressants.
It works through magnetic brain stimulation, not chemical neurotransmitters.
A 301-person RCT showed active TMS superior to sham.
Real-world data: ~58% response, ~37% remission.
TMS does not work for everyone; individual results vary.

How TMS Works When Medication Hasn't

Antidepressant medication works by altering chemical neurotransmitters in the brain (such as serotonin, norepinephrine, and dopamine). TMS works through a completely different mechanism — it uses magnetic pulses to stimulate specific brain regions involved in mood regulation, particularly the left dorsolateral prefrontal cortex.

Because TMS does not rely on the chemical pathways that medication targets, it can be effective for people whose depression has not responded to antidepressants. It does not introduce chemicals into the body and does not have the systemic side effects associated with oral medications.

FDA Clearance for Treatment-Resistant Depression

TMS devices are FDA-cleared for adults with major depressive disorder who have not achieved satisfactory improvement from prior antidepressant medication in the current episode. This means TMS is specifically intended for people whose depression has not responded to medication — not as a first-line treatment.

The first TMS device (NeuroStar) was cleared in October 2008. Later clearances on specific devices cover anxious depression, OCD, and adolescents aged 15–21.

What the Research Shows

The evidence for TMS after antidepressant failure includes:

A 301-person randomized controlled trial found active TMS superior to sham (O'Reardon et al., 2007).
A 307-patient real-world naturalistic study reported about 58% response and 37% remission (Carpenter et al., 2012).
The THREE-D trial (2018) showed theta burst TMS was non-inferior to conventional 10 Hz TMS.
TMS does not work for everyone — roughly 40% or more of patients in real-world series do not meet response criteria.

These figures describe groups, not individuals. Your own likelihood of benefit depends on your history and should be discussed with a psychiatrist.

What TMS Treatment Involves

A standard TMS course involves:

One session per day, five days a week, for about 4–6 weeks.
Each session lasts from 3 minutes (theta burst) to 37 minutes (10 Hz).
No anesthesia or sedation — patients are awake throughout.
No recovery period — patients can drive and return to normal activities after each session.
Common side effects: headache and scalp discomfort, which usually fade within the first week.

SAINT® as an Accelerated Option

For patients who cannot commit to 4–6 weeks of daily visits, SAINT® accelerated TMS offers an alternative. SAINT® delivers 50 sessions in 5 consecutive days using fMRI-guided targeting. It is FDA-cleared for the same population — adults whose depression has not improved on antidepressants.

SAINT® may be appropriate for patients who need faster treatment or who cannot take 6 weeks off work. A psychiatric evaluation determines whether conventional TMS or SAINT® is more appropriate.

What to Do Next

If antidepressants have not provided adequate relief and you are considering TMS, a psychiatric evaluation is the first step. A psychiatrist can review your medication history, confirm whether TMS is appropriate, and recommend whether conventional TMS or SAINT® may be right for you.

Do not stop current medication on your own — discuss any changes with your prescriber.

Check if you may be a candidate for TMS · Learn about SAINT® accelerated TMS · Request a consultation or call 954-827-9793.

Is it really SAINT®? 5 checks

Before you pay for any 5-day program advertised as SAINT®, confirm these five points.

1
Is the clinic listed on Magnus Medical's provider locator?
If a clinic isn't on the official Magnus Medical locator (magnusmedical.com), it is not a verified SAINT® provider. Magnus Medical locator
2
Do they do a brain MRI to personalize your target?
SAINT® requires a brain MRI to find your individual target. No scan = not SAINT®.
3
Which TMS machine and software do they use?
SAINT® runs only on the Magnus Medical system with its FDA-cleared targeting software.
4
Is the 5-day protocol FDA-cleared, or off-label?
Ask the clinic to state in writing whether their 5-day protocol is FDA-cleared or an off-label schedule.
5
Do they offer it to minors?
SAINT® is FDA-cleared for adults only. Be cautious if a clinic offers an accelerated course to a teen or child.

Watch & Learn

Understanding SAINT® TMS: How It Works & What to Expect

SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. These videos explain how it works and how it differs from conventional TMS.

SAINT® is an FDA-cleared, fMRI-guided form of TMS developed at Stanford. Most patients complete treatment in one week — not the six weeks standard TMS requires.

Follow a real patient through the five-day SAINT® treatment week

Is SAINT® TMS Right for You?

Tried antidepressants without enough relief? SAINT® TMS is an FDA-cleared, fMRI-guided treatment for adults with major depressive disorder who have not improved enough with antidepressant medication.

SAINT® uses a personalized brain target and delivers treatment over five consecutive days. It differs from standard TMS in its targeting approach, treatment schedule, and research background. In a small randomized trial, 11 of 14 people receiving active treatment reached remission at the four-week assessment, compared with 2 of 15 receiving sham treatment. Results vary, and a five-day treatment course does not guarantee remission in five days.

How SAINT® Works and How It Differs From Conventional TMS

SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. This video explains how it works, and how it differs from conventional TMS.

Conventional TMS usually means about 30 visits over 6 to 9 weeks. SAINT is five visits over five days.

What makes it different: SAINT is the only FDA-cleared depression treatment that uses an fMRI scan to personalize the stimulation target to your individual brain. A 45-minute scan maps your brain and identifies the specific circuit linked to depression. Treatment is then delivered as ten 10-minute sessions per day, with 50-minute breaks between them, across five consecutive days.

In clinical trials, 79% of participants reached remission, with an average of 2.6 days to remission. SAINT is generally well tolerated; the most common side effects reported were mild headache and temporary scalp discomfort at the treatment site.

SAINT® at Neuro Wellness TMS Centers of America

Coral Springs, Florida
Free benefits check · Self-pay options available
Call or Text: 954-827-9793

Sources: Cole et al., American Journal of Psychiatry 2020;177:716-726 and 2022;179(2):132-141. magnusmedical.com/depression-therapy. PubMed 34711062. FDA 510(k) K220177.

Insurance coverage for SAINT is currently limited and varies by plan. Individual results may vary. This video is educational and is not medical advice. Talk to a qualified clinician about whether SAINT is appropriate for you. If you are in crisis, call or text 988.